Participatory Design of Patient-centered Depression and Diabetes Care
Not Applicable
Completed
- Conditions
- DepressionType 2 Diabetes Mellitus
- Interventions
- Behavioral: Education, encouragementBehavioral: Education, encouragement, card sort
- Registration Number
- NCT02178176
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The burden of diabetes is anticipated to grow yet the proportion of adults whose diabetes is controlled is decreasing over time. This project can have a significant public health impact because we are refining and pilot testing a primary-care based intervention aimed at improving patient engagement and function which are critical components of diabetes care and are associated with improved glycemic control, lower disease-related health-care expenditures, and reduced mortality.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
- 18 years and older
- a current diagnosis of Type 2 DM
- HbA1c 7%
- current prescription for an oral hypoglycemic agent
- able to communicate in English
- willing to give informed consent
Read More
Exclusion Criteria
- acutely suicidal or psychotic (patients will not be randomized and PI or physician covering for PI will be paged immediately)
- significant cognitive impairment at baseline (a total score on Mini-Mental State Examination (MMSE) 21)
- markedly shortened life expectancy (diagnosis of metastatic cancer, end-stage renal disease on dialysis, or NYHA Class III or IV congestive heart failure)
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Education, encouragement Education, encouragement - Education, encouragement, card sort Education, encouragement, card sort -
- Primary Outcome Measures
Name Time Method Depression: nine-item Patient Health Questionnaire (PHQ-9) Baseline and 14 weeks Glycemic control: hemoglobin A1c Baseline and 14 weeks Adherence to oral hypoglycemic agents: Medication Event Monitoring System Over 14 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States